© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Plus Therapeutics, Inc. (PSTV) shows an Average True Range (ATR) of 0.06 and an Enterprise Value of 2.47M. Its average trading volume over the past 3 months is 18.44M, indicating liquidity. These fundamental metrics provide insight into PSTV's underlying financial health and market activity.
Plus Therapeutics, Inc. (PSTV) technical indicators as of December 22, 2025: the SMA 20 is -7.48%, SMA 50 at -3.42%, and SMA 200 at -3.13%. The RSI 14 value is 45.55, suggesting its current momentum. These technical analysis signals help assess PSTV's price trends and potential future movements.
Plus Therapeutics, Inc. (PSTV) stock performance overview as of December 22, 2025: The 52-week high is $2.31 (currently -75.39% below), and the 52-week low is $0.163 (currently 247.92% above). Over the past year, PSTV's performance is -55.24%, compared to the S&P 500's 12.87% change.
According to market data, Plus Therapeutics, Inc. (PSTV) stock's recent performance metrics show that over the last month, PSTV is 11.45%, with a Year-to-Date (YTD) performance of -50.57%. Over the past year, the stock has seen a -55.24% change. These figures summarize PSTV's price movements across various periods, reflecting its historical returns.
According to current financial data, PSTV stock's P/E (TTM) ratio is -2.97, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for PSTV, including P/S (8.91), P/B (12.08), and P/FCF (-2.18), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.